Zhengyuan is doveed to providing leading technologies, products and service in its strategic business of medical nebulizers. Aerosol therapy widely researched and used in America, Europe and Japan is a effective way of targeted delivery. It is preffered by WHO and GINA to be the first choice in the therapy or respiratory system disease such as asthma, COPD and etc. Due to our core technologies and registered patents in the key process of making inhalation devices, Zhengyuan plans to make innovation of the drug delivery of the prevention and treatment of respiratory system disease, infection disease, metabolic disease, body surface disease and human vaccine, which makes painless and convenient drug delivery to be accepted by the public. Based on the foundation and creative design in the R&D of inhalation devices, our products has reached or exceeded the advanced level of Germany, USA, UK and Japan. Conclusive validation acquired by foreign and domestic pharmaceutical companies in more clinical trails than any other brand. Our product is characterized by fine and consistent particles, low-power, and portable. Besides its classic application in respiratory disease, we believe our product sets a good foundation for aerosol therapy of systemic disease and body surface disease. Our company is located at Wujin, Jiangsu province and be next to Changzhou International Medical Devices City. The registered capital is 10, 000, 000 yuan. Our production line is estimated to be bale to produce 2, 000, 000 PCS per year. Warmly welcome guests from all over the world, and work together to seek our company ideal-wish people peace and health. Peace, health, wish and people.